Zhanel GG et al. |
Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia. |
2006 |
Ther Clin Risk Manag |
pmid:18360582
|
Nawarskas JJ and Snowden SS |
Critical appraisal of ticagrelor in the management of acute coronary syndrome. |
2011 |
Ther Clin Risk Manag |
pmid:22241944
|
Rafii F et al. |
Effects of treatment with antimicrobial agents on the human colonic microflora. |
2008 |
Ther Clin Risk Manag |
pmid:19337440
|
Zhou S et al. |
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. |
2005 |
Ther Clin Risk Manag |
pmid:18360537
|
Pace F et al. |
A review of rabeprazole in the treatment of acid-related diseases. |
2007 |
Ther Clin Risk Manag |
pmid:18488081
|
Oncü S |
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin. |
2007 |
Ther Clin Risk Manag |
pmid:18488076
|
Duclos AJ et al. |
Current treatment options in the management of chronic prostatitis. |
2007 |
Ther Clin Risk Manag |
pmid:18472971
|
Carrie AG and Marrie TJ |
Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department. |
2005 |
Ther Clin Risk Manag |
pmid:18360543
|
Goodman JJ and Martin SI |
Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections. |
2012 |
Ther Clin Risk Manag |
pmid:22547933
|
Werth S et al. |
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery. |
2012 |
Ther Clin Risk Manag |
pmid:22547932
|
Neely M and Kovacs A |
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. |
2009 |
Ther Clin Risk Manag |
pmid:19707276
|
Niioka T et al. |
Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. |
2006 |
Ther Drug Monit |
pmid:16778714
|
Kunicki PK and Sobieszczańska-Małek M |
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient. |
2005 |
Ther Drug Monit |
pmid:15665756
|
Zhou SF et al. |
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. |
2007 |
Ther Drug Monit |
pmid:18043468
|
Krause M |
[Resistance problems in gastrointestinal infections]. |
2002 |
Ther Umsch |
pmid:11851045
|
Bohr UR and Malfertheiner P |
Eradication of H. pylori Infection: the Challenge is on if Standard Therapy Fails. |
2009 |
Therap Adv Gastroenterol |
pmid:21180534
|
Berning M et al. |
Should quinolones come first in Helicobacter pylori therapy? |
2011 |
Therap Adv Gastroenterol |
pmid:21694812
|
Mégraud F |
The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. |
2012 |
Therap Adv Gastroenterol |
pmid:22423259
|
Gisbert JP |
Second-line rescue therapy of helicobacter pylori infection. |
2009 |
Therap Adv Gastroenterol |
pmid:21180581
|
Pinzani V et al. |
[Occurrence of anterior uveitis in a HIV patient treated with rifabutin, ethambutol, clarithromycin]. |
1995 Sep-Oct |
Therapie |
pmid:8571297
|
van Ingen J et al. |
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. |
2009 |
Thorax |
pmid:19213773
|
Andréjak C et al. |
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. |
2009 |
Thorax |
pmid:19052044
|
Essilfie AT et al. |
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. |
2015 |
Thorax |
pmid:25746630
|
Jenkins PA et al. |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. |
2008 |
Thorax |
pmid:18250184
|
Majoor CJ et al. |
Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. |
2004 |
Thorax |
pmid:15223876
|
Spencer S and Jones PW |
Time course of recovery of health status following an infective exacerbation of chronic bronchitis. |
2003 |
Thorax |
pmid:12832673
|
Brusselle GG |
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases? |
2015 |
Thorax |
pmid:25870311
|
Schweeger I et al. |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. |
2000 |
Thromb. Res. |
pmid:10704650
|
Lygren I et al. |
[Treatment of Helicobacter pylori infection]. |
1998 |
Tidsskr. Nor. Laegeforen. |
pmid:9889634
|
Farup PG |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial]. |
2003 |
Tidsskr. Nor. Laegeforen. |
pmid:14714012
|
Walrave TR et al. |
[Mania induced by antibiotic therapy]. |
|
Tijdschr Psychiatr |
pmid:27527887
|
Mukae H et al. |
Low expression of T-cell co-stimulatory molecules in bone marrow-derived dendritic cells in a mouse model of chronic respiratory infection with Pseudomonas aeruginosa. |
2010 |
Tohoku J. Exp. Med. |
pmid:20046053
|
Kaji C et al. |
Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. |
2008 |
Tohoku J. Exp. Med. |
pmid:18285669
|
De Lorenzi G et al. |
Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo). |
2018 |
Top Companion Anim Med |
pmid:30502861
|
Peters TS |
Do preclinical testing strategies help predict human hepatotoxic potentials? |
2005 |
Toxicol Pathol |
pmid:15805066
|
Cosgrove BD et al. |
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. |
2009 |
Toxicol. Appl. Pharmacol. |
pmid:19362101
|
Liu CN and Somps CJ |
Telithromycin blocks neuromuscular transmission and inhibits nAChR currents in vitro. |
2010 |
Toxicol. Lett. |
pmid:20153815
|
Pedersen JM et al. |
Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). |
2013 |
Toxicol. Sci. |
pmid:24014644
|
Guo L et al. |
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. |
2013 |
Toxicol. Sci. |
pmid:24052561
|
Sawada H et al. |
A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. |
2005 |
Toxicol. Sci. |
pmid:15342952
|
Lin Z and Will Y |
Evaluation of drugs with specific organ toxicities in organ-specific cell lines. |
2012 |
Toxicol. Sci. |
pmid:22166485
|
Jiang H et al. |
MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. |
2010 |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:20832094
|
Ani AE et al. |
Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. |
1999 Nov-Dec |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:10717760
|
Baron BW et al. |
Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. |
2003 |
Transfusion |
pmid:12919436
|
Ivetic Tkalcevic V et al. |
Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. |
2012 |
Transl Res |
pmid:22677362
|
Castro-Silva AN et al. |
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment. |
2011 |
Transpl Infect Dis |
pmid:20534038
|
Korres DS et al. |
Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. |
2007 |
Transpl Infect Dis |
pmid:17313477
|
Silva JT et al. |
Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: case report and literature review. |
2015 |
Transpl Infect Dis |
pmid:25816889
|
den Broeder AA et al. |
Disseminated Mycobacterium gordonae infection in a renal transplant recipient. |
2003 |
Transpl Infect Dis |
pmid:14617305
|
Pea F et al. |
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia. |
2015 |
Transpl Infect Dis |
pmid:26296391
|